Physician profile
Loc Lam
NPI 1538747035
$4,227.87
in general payments reported to CMS, 2019-2025
16 companies · $2,495 in 2025
The $2,495 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $528 · 2022: $261 · 2023: $321 · 2024: $623 · 2025: $2,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,924 · Grant: $1,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,923.80 |
| Grant | $1,515.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,803.77 | 2024-2025 | Infinity, Eterna, Proclaim |
| Medtronic, INC. | $620.61 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $299.72 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Astrazeneca Pharmaceuticals Lp | $247.07 | 2021-2024 | Airsupra |
| E.R. Squibb & Sons, L.L.C. | $220.48 | 2021-2022 | |
| Tersera Therapeutics LLC | $186.82 | 2025 | Prialt |
| Janssen Pharmaceuticals, INC | $185.52 | 2021 | |
| Painteq LLC | $175.99 | 2022 | |
| Gilead Sciences, INC. | $124.92 | 2024 | Vemlidy |
| Nalu Medical, INC. | $117.02 | 2024 | Nalu Neurostimulation System |
| Avanos Medical | $116.56 | 2025 | Generator |
| Alexion Pharmaceuticals, INC. | $33.06 | 2021 | |
| Melinta Therapeutics, LLC | $32.95 | 2021-2022 | |
| Stryker Corporation | $31.44 | 2025 | Augment Injectable |
| Aurinia Pharma U.S., INC. | $16.07 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loc Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.